Gastrectomy and Esophagogastrectomy for Proximal and Distal Gastric Lesions: A Comparison of Open and Laparoscopic Procedures

Laparoscopic gastrectomy is safe for benign lesions; however, such surgery for cancer remains controversial. The aim of this study is to compare outcomes in open versus laparoscopic gastrectomy. Data on patients undergoing open (n = 15) or laparoscopic (n = 52) gastrectomy revealed a mean age of 61....

Full description

Saved in:
Bibliographic Details
Published in:Surgical innovation 2009-06, Vol.16 (2), p.134-139
Main Authors: Francescutti, Valerie, Choy, Ian, Biertho, Laurent, Goldsmith, Charles H., Anvari, Mehran
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Cohort Studies
Esophagectomy - adverse effects
Esophagectomy - methods
Esophagogastric Junction - pathology
Esophagogastric Junction - surgery
Female
Gastrectomy - adverse effects
Gastrectomy - methods
Humans
Laparoscopy
Length of Stay
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Stomach Diseases - mortality
Stomach Diseases - pathology
Stomach Diseases - surgery
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Laparoscopic gastrectomy is safe for benign lesions; however, such surgery for cancer remains controversial. The aim of this study is to compare outcomes in open versus laparoscopic gastrectomy. Data on patients undergoing open (n = 15) or laparoscopic (n = 52) gastrectomy revealed a mean age of 61.7 and 70.5 years, respectively (P = .06). Mean operative time was 32.3 minutes longer in the laparoscopic group (P = .24). The difference in median length of hospital stay was 3 days (open 12 days, laparoscopic 9 days). Postoperative morbidity (< 30 days) was not different; however, there were more early respiratory complications in the open group (P = .009). There were 4/6 (66.7%) open and 2/29 (6.9%) cancer recurrences. Laparoscopic approach for treatment of gastric lesions is safe and does not have a deleterious effect on cancer-related outcome.
ISSN:1553-3506
1553-3514
DOI:10.1177/1553350609336738